Protheragen-ING
Rimegepant
inquiry
| Purity Not Available
Protheragen-ING
Rimegepant is a small molecule inhibitor of the calcitonin gene-related peptide (CGRP) receptor that blocks the action of CGRP, a potent vasodilator believed to play a role in migraine headaches. Rimegepant is approved for treatment of acute migraine attacks. In clinical trials, rimegepant was generally well tolerated with only rare instances of transient serum aminotransferase […]
More Information
Supplier Page
Protheragen-ING
Riociguat
inquiry
| Purity Not Available
Protheragen-ING
It is used for treatment of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension It has a role as a soluble guanylate cyclase activator and an antihypertensive agent.
More Information
Supplier Page
Risdiplam
inquiry
| Purity Not Available
Protheragen-ING
Risdiplam is an orally bioavailable mRNA splicing modifier used for the treatment of spinal muscular atrophy (SMA). It increases systemic SMN protein concentrations by improving the efficiency of SMN2 gene transcription.
More Information
Supplier Page
Ritalinic acid
inquiry
| Purity Not Available
Protheragen-ING
Ritalinic acid is a monocarboxylic acid that is phenylacetic acid substituted by a piperidin-2-yl group at position 2. It is a metabolite of the drug methylphenidate. It has a role as a marine xenobiotic metabolite and a drug metabolite. It is a monocarboxylic acid and a member of piperidines.
More Information
Supplier Page
Ritlecitinib
inquiry
| Purity Not Available
Protheragen-ING
Rivaroxaban
inquiry
| Purity Not Available
Protheragen-ING
Rivaroxaban is an anticoagulant and the first orally active direct factor Xa inhibitor. Unlike warfarin, routine lab monitoring of INR is not necessary.
More Information
Supplier Page
Protheragen-ING
An impurity of Rivaroxaban.Metabolite.Rivaroxaban inhibits both free Factor Xa and Factor Xa bound in the prothrombinase complex. It is a highly selective direct Factor Xa inhibitor with oral bioavailability and rapid onset of action
More Information
Supplier Page
Protheragen-ING
An impurity of Rivaroxaban. Rivaroxaban inhibits both free Factor Xa and Factor Xa bound in the prothrombinase complex. It is a highly selective direct Factor Xa inhibitor with oral bioavailability and rapid onset of action.
More Information
Supplier Page
Protheragen-ING
An impurity of Rocuronium. Rocuronium is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia to facilitate endotracheal intubation by providing skeletal muscle relaxation.
More Information
Supplier Page
RockPhos Pd G3
inquiry
| Purity Not Available
Protheragen-ING
Protheragen-ING
Rocuronium Bromide is the bromide salt form of rocuronium, an intermediate-acting quaternary aminosteroid with muscle relaxant property. Rocuronium bromide competitively binds to the nicotinic receptor at the motor end plate, and antagonizes acetylcholine binding, which results in skeletal muscle relaxation and paralysis.
More Information
Supplier Page
Ropivacaine HCL
inquiry
| Purity Not Available
Protheragen-ING
Protheragen-ING
An anilide used as a long-acting local anesthetic. It has a differential blocking effect on sensory and motor neurons.
More Information
Supplier Page
Rosmarinic acid
inquiry
| Purity Not Available
Protheragen-ING
(R)-rosmarinic acid is a stereoisomer of rosmarinic acid having (R)-configuration. It has a role as a plant metabolite and a geroprotector. It is a conjugate acid of a (R)-rosmarinate. It is an enantiomer of a (S)-rosmarinic acid.
More Information
Supplier Page
Rosuvastatin
inquiry
| Purity Not Available
Protheragen-ING
Protheragen-ING
Rotigotine
inquiry
| Purity Not Available
Protheragen-ING
Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine […]
More Information
Supplier Page
Rotundine
inquiry
| Purity Not Available
Protheragen-ING
Protheragen-ING
Protheragen-ING
5′-DMT-2’O-TBDMS-rU Phosphoramidite is a classic 2-OTBDMS phosphoramidite used to incorporate U into synthetic oligonucleotides.
More Information
Supplier Page
Protheragen-ING
Rupatadine inhibits both platelet-activating factor (PAF) and histamine (H1) effects through its interaction with specific receptors.
More Information
Supplier Page
RuPhos Pd G2
inquiry
| Purity Not Available
Protheragen-ING
Ruphos Pd G3
inquiry
| Purity Not Available
Protheragen-ING
Ruphos Pd G3 is an organic noble metal catalyst, which is mainly used as a catalyst in coupling reactions such as Suzuki, Kumada, and Negishi.
More Information
Supplier Page
Rutaecarpine
inquiry
| Purity Not Available
Protheragen-ING
Rutin
inquiry
| Purity Not Available
Protheragen-ING
Rutin is a rutinoside that is quercetin with the hydroxy group at position C-3 substituted with glucose and rhamnose sugar groups. It has a role as a metabolite and an antioxidant. It is a disaccharide derivative, a quercetin O-glucoside, a tetrahydroxyflavone and a rutinoside.
More Information
Supplier Page
Rutin
inquiry
| Purity Not Available
Protheragen-ING
Rutin is a flavonoid found in rue leaves, buckwheat, and other plants. Rutin helps prevent a couperose condition and demonstrates anti-oxidant properties.
More Information
Supplier Page
Ruxolitinib
inquiry
| Purity Not Available
Protheragen-ING
Used as the phosphate salt for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. It has a role as an antineoplastic agent and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor.
More Information
Supplier Page
Protheragen-ING
Used for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. It has a role as an antineoplastic agent and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor.
More Information
Supplier Page
Protheragen-ING
An impurity of Zolmitriptan, which is a serotonin 5-HT1 B and D receptor agonist used for the treatment of migraine.
More Information
Supplier Page
S-Phos
inquiry
| 0.99%
Protheragen-ING
S-Phos is a catalyst that is used in the preparation of thiadiazoles as DGAT1 inhibitors with potential in metabolic diseases treatment.
More Information
Supplier Page
Protheragen-ING
Sweeteners, widely used in food and drugs, are generally applied as pharmaceutical excipients to flavor oral liquids, orally disintegrating tablets, oral tablets and other dosage forms.
More Information
Supplier Page
Protheragen-ING
Sacubitril sodium is a potent and orally active NEP (neprilysin) inhibitor, with an IC50 of 5 nM. Sacubitril sodium enhances the tone of the natriuretic peptide (NP) system and exerts significant antihypertensive effects. Sacubitril sodium is a component of the heart failure medicine LCZ696. Sacubitril sodium can be used for the research of heart failure, […]
More Information
Supplier Page
Protheragen-ING
Sacubitril valsartan sodium is an angiotensin receptor-neprilysin inhibitor (ARNi) for the treatment of high blood pressure and heart failure.
More Information
Supplier Page
Protheragen-ING
Protheragen-ING
Safinamide is a highly selective MAO-B inhibitor in rat brain mitochondria, with an IC50 of 98 nM. safinamide inhibits MAO-B in human brain with an IC50 of 9 nM.
More Information
Supplier Page